Toby Wegman Net Worth

The estimated Net Worth of Toby Wegman is at least $95.3 Milión dollars as of 9 September 2019. Ms. Wegman owns over 10,000 units of Biospecifics Technologies stock worth over $82,782,013 and over the last 15 years she sold BSTC stock worth over $12,384,937. In addition, she makes $156,007 as Director at Biospecifics Technologies.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Ms. Wegman BSTC stock SEC Form 4 insiders trading

Toby has made over 22 trades of the Biospecifics Technologies stock since 2009, according to the Form 4 filled with the SEC. Most recently she sold 10,000 units of BSTC stock worth $551,700 on 9 September 2019.

The largest trade she's ever made was selling 150,000 units of Biospecifics Technologies stock on 13 September 2010 worth over $3,525,000. On average, Toby trades about 18,778 units every 146 days since 2009. As of 9 September 2019 she still owns at least 935,073 units of Biospecifics Technologies stock.

You can see the complete history of Ms. Wegman stock trades at the bottom of the page.

Toby Wegman biography

Toby Wegman serves as Director of the Company. Ms. Wegman is currently a director on the Board and has served as a director of the Company since June 2007. Ms. Wegman is the widow of our former CEO and Chairman, Edwin H. Wegman. Ms. Wegman has had a range of business-related work experiences. For five years she owned and operated a women's apparel business and prior to that managed a women's retail clothing operation. She had also been actively involved in the management of Edwin H. Wegman's business interests and finances for many years. Ms. Wegman is the stepmother of Dr. Mark Wegman, a director of the Company, and the stepmother of our former President, Thomas Wegman. Ms. Wegman is a member of the Lion of Judah, and a lifetime member of both the National Council of Jewish Women and HADASSAH. The Company believes that Ms. Wegman is qualified to serve as a member of our Board because of her business and professional experience.

What is the salary of Toby Wegman?

As the Director of Biospecifics Technologies, the total compensation of Toby Wegman at Biospecifics Technologies is $156,007. There are 4 executives at Biospecifics Technologies getting paid more, with Jennifer Chao having the highest compensation of $217,507.

How old is Toby Wegman?

Toby Wegman is 85, she's been the Director of Biospecifics Technologies since 2007. There are no older and 8 younger executives at Biospecifics Technologies.

What's Toby Wegman's mailing address?

Toby's mailing address filed with the SEC is C/O BIOSPECIFICS TECHNOLOGIES CORP., 2 RIGHTER PKWY, DE CORP CENTER II, WILMINGTON, DE, 19803.

Insiders trading at Biospecifics Technologies

Over the last 33 years, insiders at Biospecifics Technologies have traded over $67,860,045 worth of Biospecifics Technologies stock and bought 7,761,661 units worth $656,708,120 . The most active insiders traders include Capital Management, Llc Kol..., International Plc Endo a Max Link. On average, Biospecifics Technologies executives and independent directors trade stock every 73 days with the average trade being worth of $6,538,649. The most recent stock trade was executed by International Plc Endo on 2 December 2020, trading 7,344,955 units of BSTC stock currently worth $650,028,518.

What does Biospecifics Technologies do?

Complete history of Ms. Wegman stock trades at Biospecifics Technologies

Biospecifics Technologies executives and stock owners

Biospecifics Technologies executives and other stock owners filed with the SEC include:

• Jennifer Chao,
  Independent Chairman of the Board
• Michael Schamroth,
  Independent Director
• Paul Gitman,
  Independent Director
• Mark Wegman,
  Director
• Toby Wegman,
  Director
• Sarah McCabe,
  Stern Investor Relations
• Michael Sherman,
  Independent Director
• Corey Fishman,
  Independent Director
• Alex Monteith,
  Senior Vice President and Chief Business Officer
• Patrick Hutchison,
  Chief Financial Officer
• Joseph Truitt,
  Chief Executive Officer, Director
• Jeffrey Kenneth Vogel,
  
• Jyrki Mattila,
  Director
• Thomas Wegman,
  President
• Of Edwin H. Wegman Estate,
  10% owner
• Patrick M Caldwell,
  Principal Financial Officer
• Partners Lp Bio,
  10% owner
• Albert Horcher,
  
• Lawrence Dobroff,
  CFO
• Max Link,
  Director
• Henry Morgan,
  Director
• George M Gould,
  Director
• Matthew Geller,
  Director
• Capital Management, Llc Kol...,
  
• Capital Management, Llcra C...,
  
• Capital Management, Llcaldr...,
  
• Capital Management, Llc Kol...,
  
• Capital Management, Llcra C...,
  
• J Kevin Buchi,
  Chief Executive Officer
• International Plc Endo,
  10% owner